As per MRFR analysis, the US Neurovascular Devices Market Size was estimated at 1.04 (USD Billion) in 2023. The US Neurovascular Devices Market Industry is expected to grow from 1.1(USD Billion) in 2024 to 2.2 (USD Billion) by 2035. The US Neurovascular Devices Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).
The US Neurovascular Devices Market is witnessing several important trends that are shaping its future. One major driver is the increasing prevalence of neurovascular diseases such as stroke and aneurysms, leading to a greater demand for advanced medical devices. The aging population in the US also plays a significant role, as older individuals are more susceptible to neurovascular conditions. Additionally, advancements in technology are driving innovation, with companies developing minimally invasive devices that enhance patient outcomes.
These new technologies are often supported by favorable regulatory policies that streamline the approval processes for new neurovascular devices.There are numerous opportunities to be explored within the US market. For instance, there is potential for growth in specialized devices aimed at treating specific conditions within neurovascular issues. The rise of telemedicine and remote monitoring solutions also offers avenues to improve patient engagement and follow-up care.
Furthermore, partnerships between device manufacturers and healthcare providers can facilitate the adoption of new technologies, ultimately improving treatment efficacy. Recent trends indicate an increasing focus on safety and efficacy in the development of neurovascular devices. This is evident through rigorous clinical trials and post-market surveillance that prioritize patient safety.There is also a significant shift toward using artificial intelligence in the analysis of imaging and treatment planning, further enhancing the accuracy and effectiveness of interventions.
As patient awareness regarding neurovascular issues rises, there is an increasing demand for educational resources and support, prompting companies to enhance their outreach efforts. Collectively, these trends reflect a dynamic and evolving landscape within the US Neurovascular Devices Market, characterized by innovation, consumer demand, and a focus on improved healthcare outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In recent years, the United States has been witnessing a significant rise in neurological disorders, particularly stroke and aneurysms, which is expected to drive the demand for neurovascular devices. A report from the Centers for Disease Control and Prevention (CDC) indicates that nearly 795,000 people in the United States experience a stroke each year, which translates to approximately one in every 6 deaths in the country, making stroke a leading cause of death in the US.Additionally, with an aging population as the Baby Boomer generation continues to age, projections suggest that the incidence of conditions like ischemic stroke will increase by nearly 20% over the next decade.
Major organizations, such as the American Heart Association, are actively investing in educational and preventive programs to reduce neurological disorders, thereby increasing awareness and demand for neurovascular therapies in the US Neurovascular Devices Market Industry.
The growth of the US Neurovascular Devices Market Industry is significantly fueled by continuous innovations in technology. Advanced devices such as aspiration catheters, stent retrievers, and flow diverters have improved the effectiveness of neurovascular procedures. According to findings shared by the Food and Drug Administration (FDA), neurovascular devices are now seeing enhanced performance with reduced complications due to these technological advancements.Furthermore, numerous companies, including Medtronic and Stryker, are heavily investing in Research and Development (R&D) to enhance device efficacy, including devices that provide real-time imaging and minimally invasive techniques, which cater to a growing preference for outpatient procedures.
These advancements are projected to play a crucial role in driving market growth in the coming years.
In an effort to improve healthcare access and treatment outcomes, the US government has implemented various policies and initiatives in recent years. The Affordable Care Act has played a significant role in expanding healthcare coverage, thus benefitting more patients requiring neurovascular treatments. According to the Department of Health and Human Services, the expansion of Medicaid in various states has enabled lower-income populations to access critical neurovascular care, leading to higher demand for neurovascular devices.Additionally, government funding for stroke treatment initiatives and guidelines for addressing neurological disorders have encouraged advancements in the US Neurovascular Devices Market Industry.
Such initiatives are crucial for improving outcomes and reducing the overall burden of disease in the US.
The Device Type segment of the US Neurovascular Devices Market encompasses several critical categories, each playing a decisive role in addressing neurovascular conditions. Interventional Neurology Devices represent a crucial component, focusing on advanced minimally invasive techniques that facilitate effective treatment of conditions like aneurysms and arteriovenous malformations. Their significance continues to rise with an increased preference for patient-centric approaches that reduce recovery times and improve outcomes. Neurovascular Stents are vital as they provide support for narrowed or weakened blood vessels in the brain, preventing complications such as strokes.
These devices are gaining traction due to ongoing technological advancements that enhance their efficacy and safety. Embolic Agents serve as another major category, utilized primarily in occluding blood vessels to mitigate risks associated with hemorrhagic events. Their contribution to treatment strategies has been pivotal, given the rising incidence of related health complications. Catheters are fundamental tools in the neurovascular field, allowing for precise navigation within the vascular system to deliver therapies or contrast agents.
The expansion of catheter technologies enhances procedural success rates and minimizes potential risks during neurovascular interventions. Lastly, Flow Diverters are becoming increasingly significant as they enable the treatment of large and complex vascular lesions through a flow-modifying mechanism. Their role in promoting stable hemodynamics makes them an essential asset in neurovascular treatments. Overall, the Device Type segment reflects a diversifying landscape with continued innovation and adoption that addresses the evolving needs of patients in the US. Ongoing trends, such as the integration of robotics and imaging advancements, promise to shape the future direction of these devices, and the overall growth of the US Neurovascular Devices Market underlines the importance of this segment.
The interplay of technological enhancement, regulatory approvals, and the growing aging population further highlights the importance of each category in the market, ensuring that these devices will continue to play a crucial role in the management of neurovascular diseases.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Neurovascular Devices Market is characterized by its diverse applications that address a range of critical conditions related to the vascular system of the brain. Notably, Aneurysm Treatment represents a significant portion of the market, as the prevalence of aneurysms necessitates advanced therapies and devices. Similarly, Arteriovenous Malformation Treatment is crucial because these malformations can lead to serious health complications and require innovative surgical approaches and devices for management. The Intracranial Atherosclerotic Disease segment emphasizes the rising incidence of cerebrovascular diseases, driving demand for effective treatment solutions.Moreover, the increasing rates of Ischemic Stroke and Hemorrhagic Stroke highlight the urgent need for neurovascular devices that can enhance patient outcomes and reduce the risk of recurrence.
These segments collectively demonstrate the importance of effective neurovascular treatments, with each application serving specific patient needs while contributing to the overall growth of the US Neurovascular Devices Market. With advancements in technology, research and development are poised to play an essential role in addressing the challenges posed by these conditions, ultimately leading to improved therapeutic options for patients across the United States.
The End Use segment of the US Neurovascular Devices Market is critical, as it includes key healthcare facilities like Hospitals, Ambulatory Surgical Centers, and Specialty Clinics, which are vital for the treatment and management of neurovascular conditions. Hospitals typically serve as the primary sites for advanced neurovascular interventions, given their capacity for comprehensive care and access to sophisticated technology. In contrast, Ambulatory Surgical Centers are gaining traction due to their cost-effectiveness and efficiency in performing outpatient procedures, thus catering to patients who require less intensive treatment.Specialty Clinics focus specifically on neurovascular care, offering tailored services and expertise that enhance patient outcomes.
The combination of these end-use facilities reflects an evolving landscape, where increased investment in healthcare infrastructure and technological advancements drive market growth. Challenges, such as regulatory hurdles and high costs of neurovascular devices, present opportunities for innovation and collaboration among stakeholders. With the rising prevalence of neurovascular disorders, the importance of these end-use settings continues to grow, highlighting their significant role in shaping the overall landscape of the US Neurovascular Devices Market.
The US Neurovascular Devices Market has exhibited considerable dynamism, driven by a blend of technological advancements, an aging population, and an increasing prevalence of neurological disorders such as stroke and aneurysms. Competitive insights in this market highlight a range of companies leveraging innovation to enhance patient outcomes and procedural efficiency. Key players are focusing on the development of next-generation devices that not only improve the effectiveness of treatment but also minimize risks for patients. The strategic landscape consists of various companies actively pursuing partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolios. As a result, this competitive environment is contributing to rapid advances in neurovascular therapies and an overall enhancement in healthcare delivery for patients suffering from neurovascular conditions.
Neuravi, as a competitor in the US Neurovascular Devices Market, has established a solid presence by emphasizing innovative solutions specifically designed for neurovascular procedures. The company is recognized for its advanced thrombectomy systems, targeting the effective removal of blood clots from cerebral vessels. Neuravi's unique technology aims to reduce procedural times and enhance the overall safety profile of interventions. Their commitment to research and development enables them to stay ahead of market trends and regulatory changes, allowing the company to bring impactful, high-quality products to the market. The strength of Neuravi lies in its focus on clinician feedback to enhance product design, fostering relationships with healthcare professionals that bolster brand loyalty and encourage wider adoption of their devices.
B. Braun is a significant player in the US Neurovascular Devices Market, known for a diverse range of high-quality medical devices and solutions. The company offers a number of key products and services tailored for neurovascular treatments, including embolization coils and microcatheters designed for minimally invasive procedures. B. Braun maintains a strong market presence due to its established reputation and extensive distribution network, enabling access to a wide variety of healthcare facilities across the United States. The company has been actively involved in mergers and acquisitions aimed at expanding its product lineup and enhancing its technological capabilities. This strategic approach ensures a robust competitive edge while affirming B. Braun's commitment to innovation and excellence in patient care in the neurovascular field. Its ability to combine cutting-edge technology with reliable service solidifies B. Braun's position as a leader in the US market.
The US Neurovascular Devices Market has seen significant developments recently, notably in the areas of product advancements and market dynamics. As of October 2023, companies such as Medtronic and Boston Scientific have been leading in the innovation of neurovascular technologies, introducing devices like the Embozene microspheres and advancements in stent retrievers that enhance the treatment of cerebrovascular diseases. Additionally, Neuravi has made strides in the development of neurothrombectomy devices, contributing to improved patient outcomes. The market is also witnessing robust growth, driven by an increasing prevalence of neurological disorders and advancements in healthcare technologies. Mergers and acquisitions have been pivotal, with Cerenovus acquiring certain assets from Medtronic in July 2023 to strengthen their portfolio.
Furthermore, Johnson and Johnson announced in August 2023 a strategic partnership with Abbott Laboratories focused on expanding the accessibility of cutting-edge neurovascular devices. Over the past two to three years, significant investments have been directed towards Research and Development across these companies, thereby enhancing competitive strategies and expanding market reach within the US Neurovascular Devices industry.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.04(USD Billion) |
| MARKET SIZE 2024 | 1.1(USD Billion) |
| MARKET SIZE 2035 | 2.2(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Neuravi, B. Braun, Institute for Neuroinnovation, Medtronic, Boston Scientific, Abbott Laboratories, Nico Neurovascular, Cerenovus, Stryker, MicroVention, Terumo, Penumbra, Asahi Intecc, Johnson and Johnson |
| SEGMENTS COVERED | Device Type, Application, End Use |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Increased prevalence of neurovascular diseases, Growing geriatric population, Rising awareness and diagnosis, Expanding minimally invasive procedures |
| KEY MARKET DYNAMICS | Aging population increasing demand, Rising prevalence of neurological disorders, Advancements in device technology, Growing awareness and diagnosis, Favorable reimbursement policies |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Neurovascular Devices Market is expected to be valued at 1.1 billion USD in 2024.
The market is expected to grow at a CAGR of 6.504 percent from 2025 to 2035.
By 2035, the market is projected to reach a size of 2.2 billion USD.
Interventional Neurology Devices are expected to dominate, projected to reach 0.7 billion USD by 2035.
Major players include Medtronic, Boston Scientific, Abbott Laboratories, and Stryker among others.
Neurovascular Stents are expected to be valued at 0.25 billion USD in 2024.
Technological advancements and stringent regulations pose challenges to market growth.
Innovations in device technology and increasing prevalence of neurovascular diseases present growth opportunities.
Embolic Agents are projected to reach a value of 0.4 billion USD by 2035.
The market for Catheters is expected to grow from 0.15 billion USD in 2024 to 0.3 billion USD by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
